V
Virpax Pharmaceuticals D
D
VRPX
0.46800
USD
-0.10
(-17.15%)
Market Closed
Volume
84,402
EPS
-5
Div Yield
-
P/E
-0
Market Cap
3,784,988
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Virpax Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.